Immix Biopharma, Inc.
IMMX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $62 | $120 | $30 | $47 |
| - Cash | $18 | $18 | $13 | $18 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $46 | $102 | $17 | $29 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$23 | -$16 | -$8 | -$24 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$15 | -$8 | -$24 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.76 | -0.89 | -0.59 | -6.64 |
| % Growth | 14.6% | -50.8% | 91.1% | – |
| Operating Cash Flow | -$15 | -$11 | -$7 | -$2 |
| Capital Expenditures | -$1 | -$0 | $0 | -$0 |
| Free Cash Flow | -$16 | -$11 | -$7 | -$2 |